WHO ICTRP trial
The safety and efficacy of marginal donor for lung transplantation with…
ChiCTR2100047167 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2100047167 |
|---|---|
| Public title | The safety and efficacy of marginal donor for lung transplantation with normothermic ex-vivo lung perfusion (EVLP): a single-center prospective non-randomized controlled clinical trial |
| Scientific title | The safety and efficacy of marginal donor for lung transplantation with normothermic ex-vivo lung perfusion (EVLP): a single-center prospective non-randomized controlled clinical trial |
| Primary sponsor | Shanghai Pulmonary Hospital, Tongji University School of Medicine |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 0 |
| Countries | China |
| Conditions | Lung transplantation |
| Interventions | EVLP group:ex-vivo lung perfusion;control group:Nil |
| Registration date | Jun 9, 2021 |
| Target size | EVLP group:10;control group:10 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: